| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.607 | 0.004 | 0.607 | Peroxidase inhibitor | 0.247 0.048 CID_154700092 | ||
| 0.608 | 0.006 | 0.608 | GABA C receptor rho-3 antagonist | 0.306 0.112 CID_154700092 | ||
| 0.616 | 0.017 | 0.616 | Aldehyde oxidase inhibitor | |||
| 0.515 | 0.025 | 0.515 | 5 Hydroxytryptamine release stimulant | |||
| 0.476 | 0.015 | 0.476 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.493 | 0.035 | 0.493 | 5 Hydroxytryptamine release inhibitor | |||
| 0.46 | 0.006 | 0.46 | 5 Hydroxytryptamine uptake stimulant | 0.227 0.108 CID_154700092 | ||
| 0.483 | 0.035 | 0.608 | Cholesterol antagonist | 0.608 0.018 CID_154700092 | CID_154700092 | |
| 0.452 | 0.019 | 0.452 | Dyrk kinase inhibitor | |||
| 0.443 | 0.03 | 0.443 | 12-Lipoxygenase inhibitor | |||
| 0.439 | 0.052 | 0.544 | Antiobesity | 0.544 0.029 CID_154700092 | CID_154700092 | |
| 0.369 | 0.006 | 0.369 | Cystathionine beta-synthase inhibitor | 0.1 0.077 CID_154700092 | ||
| 0.346 | 0.005 | 0.346 | Succinate dehydrogenase inhibitor | 0.238 0.027 CID_154700092 | ||
| 0.346 | 0.009 | 0.346 | Heat shock protein 90 alpha antagonist | |||
| 0.339 | 0.01 | 0.339 | Neurotrophic factor enhancer | |||
| 0.364 | 0.041 | 0.364 | Calcium channel activator | 0.241 0.158 CID_154700092 | ||
| 0.336 | 0.026 | 0.445 | RNA-directed DNA polymerase inhibitor | 0.445 0.014 CID_154700092 | CID_154700092 | |
| 0.314 | 0.008 | 0.314 | Heat shock protein 90 antagonist | |||
| 0.324 | 0.023 | 0.324 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.379 | 0.084 | 0.379 | 15-Lipoxygenase inhibitor | 0.232 0.18 CID_154700092 | ||
| 0.304 | 0.012 | 0.304 | NADPH oxidase inhibitor | |||
| 0.291 | 0.005 | 0.291 | Estrogen receptor beta antagonist | |||
| 0.333 | 0.051 | 0.333 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.282 | 0.004 | 0.282 | Glutamate release inhibitor | 0.1 0.043 CID_154700092 | ||
| 0.274 | 0.006 | 0.274 | Potassium channel (Ca-activated) activator | |||
| 0.275 | 0.007 | 0.275 | Estrogen antagonist | |||
| 0.289 | 0.025 | 0.289 | Mcl-1 antagonist | |||
| 0.355 | 0.098 | 0.355 | Histamine release inhibitor | 0.285 0.132 CID_154700092 | ||
| 0.341 | 0.086 | 0.341 | Prostaglandin dehydrogenase inhibitor | |||
| 0.29 | 0.035 | 0.29 | Anesthetic general | |||
| 0.262 | 0.009 | 0.262 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.248 | 0.005 | 0.248 | HIV-1 integrase (Overall Integration) inhibitor | 0.171 0.019 CID_154700092 | ||
| 0.296 | 0.061 | 0.296 | Insulysin inhibitor | |||
| 0.239 | 0.006 | 0.239 | Estrogen receptor alpha antagonist | |||
| 0.288 | 0.056 | 0.288 | Antiamyloidogenic | |||
| 0.365 | 0.134 | 0.365 | Caspase 9 stimulant | |||
| 0.24 | 0.009 | 0.24 | Histidine decarboxylase inhibitor | |||
| 0.235 | 0.006 | 0.235 | Creatine kinase inhibitor | 0.121 0.04 CID_154700092 | ||
| 0.291 | 0.064 | 0.291 | Aryl hydrocarbon receptor agonist | |||
| 0.233 | 0.007 | 0.233 | Interleukin 8 antagonist | 0.11 0.076 CID_154700092 | ||
| 0.227 | 0.009 | 0.227 | NADH dehydrogenase inhibitor | 0.109 0.036 CID_154700092 | ||
| 0.254 | 0.037 | 0.477 | Dual specificity phosphatase inhibitor | 0.477 0.007 CID_154700092 | CID_154700092 | |
| 0.249 | 0.033 | 0.249 | Nitric-oxide synthase stimulant | |||
| 0.27 | 0.054 | 0.27 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.224 | 0.01 | 0.224 | Uric acid excretion stimulant | |||
| 0.229 | 0.017 | 0.229 | GABA C receptor rho-2 antagonist | |||
| 0.225 | 0.014 | 0.225 | Arachidonic acid antagonist | 0.175 0.059 CID_154700092 | ||
| 0.27 | 0.063 | 0.376 | Superoxide dismutase inhibitor | 0.376 0.031 CID_154700092 | CID_154700092 | |
| 0.249 | 0.043 | 0.249 | Non-steroidal antiinflammatory agent | 0.145 0.121 CID_154700092 | ||
| 0.226 | 0.021 | 0.294 | Cholesterol synthesis inhibitor | 0.294 0.012 CID_154700092 | CID_154700092 | |
| 0.213 | 0.011 | 0.213 | Alcohol dehydrogenase inhibitor | |||
| 0.217 | 0.016 | 0.217 | UDP-glucose 4-epimerase inhibitor | |||
| 0.207 | 0.006 | 0.207 | Potassium channel large-conductance Ca-activated activator | |||
| 0.285 | 0.086 | 0.285 | Streptokinase A inhibitor | |||
| 0.28 | 0.081 | 0.28 | Lipoxygenase inhibitor | |||
| 0.331 | 0.137 | 0.331 | Cyclophilin D inhibitor | 0.305 0.158 CID_154700092 | ||
| 0.223 | 0.028 | 0.223 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.198 | 0.004 | 0.198 | Lanosterol 14 alpha demethylase inhibitor | 0.085 0.081 CID_154700092 | ||
| 0.347 | 0.154 | 0.347 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.21 | 0.017 | 0.21 | Carbonic anhydrase XV inhibitor | 0.137 0.036 CID_154700092 | ||
| 0.239 | 0.048 | 0.239 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.264 | 0.074 | 0.264 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.203 | 0.014 | 0.203 | 5 Hydroxytryptamine 3A agonist | |||
| 0.223 | 0.035 | 0.223 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.212 | 0.024 | 0.212 | Catenin beta inhibitor | |||
| 0.202 | 0.015 | 0.202 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.194 | 0.01 | 0.194 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.262 | 0.079 | 0.262 | Transcription factor STAT inhibitor | |||
| 0.187 | 0.005 | 0.187 | NMDA receptor subunit 3B antagonist | |||
| 0.186 | 0.004 | 0.186 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.072 0.02 CID_154700092 | ||
| 0.309 | 0.129 | 0.37 | Antibacterial | 0.37 0.091 CID_154700092 | CID_154700092 | |
| 0.295 | 0.118 | 0.295 | Immunosuppressant | |||
| 0.222 | 0.045 | 0.222 | Amyloid beta precursor protein antagonist | |||
| 0.236 | 0.059 | 0.236 | ErbB-1 antagonist | |||
| 0.216 | 0.039 | 0.531 | Diuretic | 0.531 0.006 CID_154700092 | CID_154700092 | |
| 0.212 | 0.04 | 0.212 | Amylase inhibitor | |||
| 0.186 | 0.019 | 0.186 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.202 | 0.036 | 0.202 | ATPase inhibitor | |||
| 0.18 | 0.014 | 0.18 | AMP-activated protein kinase stimulant | |||
| 0.233 | 0.071 | 0.233 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.191 | 0.03 | 0.191 | Aldehyde dehydrogenase inhibitor | |||
| 0.201 | 0.04 | 0.201 | Melanin inhibitor | |||
| 0.17 | 0.013 | 0.17 | Ca2+-transporting ATPase inhibitor | |||
| 0.18 | 0.025 | 0.18 | GABA C receptor agonist | |||
| 0.176 | 0.022 | 0.176 | Pregnane X receptor agonist | 0.154 0.045 CID_154700092 | ||
| 0.173 | 0.02 | 0.173 | GABA C receptor antagonist | 0.13 0.043 CID_154700092 | ||
| 0.172 | 0.02 | 0.172 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.157 | 0.004 | 0.157 | GABA B receptor agonist | 0.09 0.025 CID_154700092 | ||
| 0.166 | 0.014 | 0.166 | DOPA decarboxylase inhibitor | |||
| 0.183 | 0.033 | 0.183 | CF transmembrane conductance regulator agonist | |||
| 0.168 | 0.02 | 0.211 | NMDA receptor antagonist | 0.211 0.013 CID_154700092 | CID_154700092 | |
| 0.156 | 0.01 | 0.156 | Prostaglandin-E synthase inhibitor | |||
| 0.159 | 0.014 | 0.159 | Dopamine D1 antagonist | |||
| 0.161 | 0.016 | 0.161 | Transcription factor STAT6 inhibitor | |||
| 0.157 | 0.014 | 0.157 | MAP kinase kinase 1 inhibitor | |||
| 0.184 | 0.04 | 0.195 | Alkaline phosphatase inhibitor | 0.195 0.035 CID_154700092 | CID_154700092 | |
| 0.156 | 0.015 | 0.156 | CYP2A6 inhibitor | |||
| 0.26 | 0.12 | 0.26 | Transcription factor NF kappa B inhibitor | |||
| 0.2 | 0.062 | 0.2 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.231 | 0.093 | 0.231 | Interleukin agonist | |||
| 0.142 | 0.004 | 0.142 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.183 | 0.046 | 0.183 | Neurotensin receptor agonist | |||
| 0.209 | 0.076 | 0.209 | MAP kinase kinase 2 inhibitor | |||
| 0.142 | 0.009 | 0.142 | GABA aminotransferase inhibitor | |||
| 0.137 | 0.005 | 0.137 | NMDA receptor subunit 3A antagonist | |||
| 0.17 | 0.038 | 0.17 | Glutamate receptor antagonist | 0.134 0.062 CID_154700092 | ||
| 0.137 | 0.005 | 0.137 | Aryl hydrocarbon receptor antagonist | |||
| 0.15 | 0.019 | 0.15 | Electrolyte absorption antagonist | |||
| 0.154 | 0.023 | 0.154 | Beta glucuronidase inhibitor | |||
| 0.184 | 0.054 | 0.401 | Protein-tyrosine phosphatase inhibitor | 0.401 0.009 CID_154700092 | CID_154700092 | |
| 0.2 | 0.071 | 0.2 | I kappa B kinase epsilon inhibitor | |||
| 0.136 | 0.007 | 0.136 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.135 | 0.008 | 0.135 | D-Ala-D-Ala ligase inhibitor | |||
| 0.14 | 0.013 | 0.14 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.193 | 0.066 | 0.193 | LIM domain kinase 1 inhibitor | |||
| 0.167 | 0.042 | 0.167 | MAP kinase kinase inhibitor | |||
| 0.144 | 0.021 | 0.144 | Aminoacyl-tRNA synthetase inhibitor | 0.095 0.052 CID_154700092 | ||
| 0.222 | 0.099 | 0.222 | DNA damaging | |||
| 0.133 | 0.012 | 0.187 | Glycine receptor antagonist | 0.187 0.004 CID_154700092 | CID_154700092 | |
| 0.148 | 0.029 | 0.148 | Carbonic anhydrase III inhibitor | 0.118 0.045 CID_154700092 | ||
| 0.173 | 0.055 | 0.173 | Interferon gamma antagonist | |||
| 0.142 | 0.025 | 0.142 | GABA C receptor rho-1 antagonist | |||
| 0.179 | 0.062 | 0.204 | Phospholipase C inhibitor | 0.204 0.041 CID_154700092 | CID_154700092 | |
| 0.122 | 0.006 | 0.122 | Heat shock protein 90 beta antagonist | |||
| 0.162 | 0.047 | 0.162 | Sodium channel (voltage-gated) blocker | 0.113 0.093 CID_154700092 | ||
| 0.156 | 0.041 | 0.156 | Adenylate cyclase inhibitor | |||
| 0.163 | 0.049 | 0.163 | c-Src kinase inhibitor | |||
| 0.153 | 0.04 | 0.153 | Protein kinase (CK2) alpha inhibitor | |||
| 0.12 | 0.009 | 0.12 | NMDA receptor glycine site agonist | 0.055 0.051 CID_154700092 | ||
| 0.144 | 0.032 | 0.144 | CC chemokine 6 receptor antagonist | |||
| 0.124 | 0.013 | 0.251 | Estrogen agonist | 0.251 0.006 CID_154700092 | CID_154700092 | |
| 0.162 | 0.051 | 0.163 | Cyclooxygenase 1 inhibitor | 0.163 0.05 CID_154700092 | CID_154700092 | |
| 0.139 | 0.03 | 0.139 | Sphingomyelinase inhibitor | |||
| 0.158 | 0.05 | 0.158 | Adenylate cyclase stimulant | 0.145 0.071 CID_154700092 | ||
| 0.144 | 0.036 | 0.144 | Protein kinase (CK2) inhibitor | |||
| 0.147 | 0.039 | 0.147 | Ferrochelatase inhibitor | |||
| 0.167 | 0.06 | 0.167 | Hexokinase inhibitor | |||
| 0.209 | 0.104 | 0.209 | Neuropeptide Y2 antagonist | |||
| 0.167 | 0.061 | 0.167 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.126 | 0.022 | 0.246 | NMDA 2 receptor antagonist | 0.246 0.006 CID_154700092 | CID_154700092 | |
| 0.129 | 0.026 | 0.129 | Porphobilinogen synthase inhibitor | |||
| 0.129 | 0.027 | 0.22 | Protein kinase C zeta inhibitor | 0.22 0.009 CID_154700092 | CID_154700092 | |
| 0.152 | 0.051 | 0.152 | Nav1.6 sodium channel blocker | |||
| 0.104 | 0.003 | 0.104 | Pregnane X receptor antagonist | |||
| 0.187 | 0.087 | 0.187 | Insulin sensitizer | |||
| 0.157 | 0.057 | 0.157 | MAP kinase 3 inhibitor | |||
| 0.187 | 0.089 | 0.187 | Pyruvate kinase inhibitor | |||
| 0.119 | 0.022 | 0.119 | Cannabinoid receptor antagonist | |||
| 0.105 | 0.008 | 0.105 | Estrogen receptor alpha agonist | |||
| 0.115 | 0.017 | 0.115 | HIV-1 integrase inhibitor | 0.108 0.02 CID_154700092 | ||
| 0.112 | 0.015 | 0.156 | NMDA receptor agonist | 0.156 0.007 CID_154700092 | CID_154700092 | |
| 0.121 | 0.025 | 0.121 | Macrophage migration inhibitory factor inhibitor | |||
| 0.155 | 0.059 | 0.155 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.133 | 0.04 | 0.143 | Nav1.5 sodium channel blocker | 0.143 0.031 CID_154700092 | CID_154700092 | |
| 0.109 | 0.016 | 0.109 | Glycine receptor agonist | |||
| 0.107 | 0.014 | 0.107 | Cannabinoid CB1 receptor antagonist | |||
| 0.103 | 0.011 | 0.124 | Estrogen receptor beta agonist | 0.124 0.009 CID_154700092 | CID_154700092 | |
| 0.156 | 0.065 | 0.156 | Cyclooxygenase inhibitor | |||
| 0.149 | 0.059 | 0.149 | Sodium channel blocker | |||
| 0.099 | 0.009 | 0.099 | 5 Hydroxytryptamine 2 agonist | |||
| 0.103 | 0.015 | 0.103 | Purinergic P2X1 antagonist | |||
| 0.134 | 0.046 | 0.134 | GABA receptor agonist | |||
| 0.141 | 0.054 | 0.141 | Nav1.3 sodium channel blocker | |||
| 0.089 | 0.003 | 0.089 | CF transmembrane conductance regulator antagonist | |||
| 0.119 | 0.033 | 0.306 | Triose-phosphate isomerase inhibitor | 0.306 0.005 CID_154700092 | CID_154700092 | |
| 0.141 | 0.056 | 0.141 | Cyclooxygenase 3 inhibitor | |||
| 0.16 | 0.077 | 0.16 | Src kinase inhibitor | |||
| 0.112 | 0.029 | 0.115 | Bile acid receptor antagonist | 0.115 0.024 CID_154700092 | CID_154700092 | |
| 0.095 | 0.013 | 0.095 | Dihydroorotate dehydrogenase inhibitor | 0.05 0.037 CID_154700092 | ||
| 0.087 | 0.005 | 0.087 | Dopamine D5 agonist | |||
| 0.142 | 0.06 | 0.142 | Cyclooxygenase 2 inhibitor | 0.133 0.068 CID_154700092 | ||
| 0.088 | 0.006 | 0.088 | Liver X receptor alpha agonist | |||
| 0.149 | 0.067 | 0.275 | Cell wall synthesis inhibitor | 0.275 0.012 CID_154700092 | CID_154700092 | |
| 0.102 | 0.021 | 0.102 | Aromatase inhibitor | |||
| 0.094 | 0.013 | 0.094 | Glutamate (mGluR6) antagonist | |||
| 0.129 | 0.048 | 0.129 | TRPA1 agonist | 0.125 0.052 CID_154700092 | ||
| 0.104 | 0.023 | 0.104 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.148 | 0.068 | 0.148 | Neuropeptide Y1 antagonist | |||
| 0.112 | 0.032 | 0.112 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.165 | 0.084 | 0.502 | Dual specificity phosphatase 3 inhibitor | 0.502 0.007 CID_154700092 | CID_154700092 | |
| 0.101 | 0.021 | 0.101 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.149 | 0.069 | 0.149 | Thiol protease inhibitor | |||
| 0.091 | 0.012 | 0.091 | Botulinum neurotoxin type A inhibitor | |||
| 0.083 | 0.004 | 0.083 | ATP citrate lysase inhibitor | |||
| 0.113 | 0.035 | 0.185 | Catalase inhibitor | 0.185 0.018 CID_154700092 | CID_154700092 | |
| 0.083 | 0.005 | 0.083 | Glucagon receptor antagonist | |||
| 0.082 | 0.004 | 0.082 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.081 | 0.004 | 0.081 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.047 0.019 CID_154700092 | ||
| 0.088 | 0.011 | 0.088 | CD45 antagonist | |||
| 0.118 | 0.042 | 0.136 | Anabolic | 0.136 0.026 CID_154700092 | CID_154700092 | |
| 0.124 | 0.049 | 0.124 | Protein kinase C gamma inhibitor | |||
| 0.142 | 0.067 | 0.142 | Heat shock protein 70 antagonist | |||
| 0.087 | 0.014 | 0.087 | MDM2 inhibitor | |||
| 0.099 | 0.026 | 0.247 | HIV-1 integrase (3'-Processing) inhibitor | 0.247 0.007 CID_154700092 | CID_154700092 | |
| 0.089 | 0.016 | 0.089 | NMDA 2A receptor antagonist | 0.058 0.031 CID_154700092 | ||
| 0.107 | 0.035 | 0.107 | Carbonic anhydrase VI inhibitor | 0.086 0.05 CID_154700092 | ||
| 0.091 | 0.019 | 0.097 | NMDA 2C receptor antagonist | 0.097 0.017 CID_154700092 | CID_154700092 | |
| 0.091 | 0.019 | 0.091 | 5 Hydroxytryptamine 2A agonist | |||
| 0.092 | 0.02 | 0.092 | Alcohol oxidase inhibitor | |||
| 0.088 | 0.017 | 0.088 | Exportin-1 inhibitor | |||
| 0.098 | 0.027 | 0.098 | Estrogen-related receptor beta agonist | |||
| 0.088 | 0.018 | 0.088 | Cannabinoid CB2 receptor antagonist | |||
| 0.122 | 0.052 | 0.168 | Aminopeptidase B inhibitor | 0.168 0.031 CID_154700092 | CID_154700092 | |
| 0.086 | 0.016 | 0.086 | Fatty acid synthase inhibitor | |||
| 0.117 | 0.048 | 0.117 | Urease inhibitor | |||
| 0.112 | 0.044 | 0.112 | DNA directed RNA polymerase inhibitor | |||
| 0.133 | 0.065 | 0.133 | Toll-Like receptor 2 antagonist | |||
| 0.108 | 0.041 | 0.108 | Androgen antagonist | |||
| 0.076 | 0.009 | 0.076 | Dihydroorotase inhibitor | |||
| 0.2 | 0.133 | 0.2 | Transcription factor STAT3 inhibitor | |||
| 0.101 | 0.034 | 0.101 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.07 | 0.005 | 0.07 | Liver X receptor beta antagonist | |||
| 0.134 | 0.069 | 0.169 | Nav1.2 sodium channel blocker | 0.169 0.047 CID_154700092 | CID_154700092 | |
| 0.11 | 0.046 | 0.11 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.128 | 0.065 | 0.128 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.105 | 0.042 | 0.105 | Histamine N-methyltransferase inhibitor | |||
| 0.077 | 0.014 | 0.077 | 5 Hydroxytryptamine 7 agonist | |||
| 0.155 | 0.094 | 0.155 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.088 | 0.027 | 0.269 | HIV-1 integrase (Strand Transfer) inhibitor | 0.269 0.005 CID_154700092 | CID_154700092 | |
| 0.067 | 0.007 | 0.067 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.079 | 0.018 | 0.079 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.164 | 0.104 | 0.164 | Psychostimulant | |||
| 0.088 | 0.028 | 0.088 | Vanilloid 4 agonist | |||
| 0.083 | 0.024 | 0.083 | Dopamine uptake inhibitor | |||
| 0.106 | 0.048 | 0.106 | Glutamate (mGluR7) agonist | |||
| 0.069 | 0.011 | 0.069 | Urate transporter 1 inhibitor | |||
| 0.092 | 0.035 | 0.092 | Glutamate dehydrogenase inhibitor | |||
| 0.085 | 0.028 | 0.106 | Phospholipase D inhibitor | 0.106 0.011 CID_154700092 | CID_154700092 | |
| 0.11 | 0.054 | 0.11 | Adenylate kinase inhibitor | |||
| 0.089 | 0.033 | 0.089 | Benzodiazepine agonist | |||
| 0.074 | 0.019 | 0.074 | Sphingosine kinase 2 inhibitor | |||
| 0.066 | 0.01 | 0.066 | Dopamine beta hydroxylase inhibitor | |||
| 0.074 | 0.019 | 0.074 | AMPA receptor antagonist | |||
| 0.067 | 0.014 | 0.067 | Adenylate cyclase 1 inhibitor | |||
| 0.147 | 0.094 | 0.147 | Interleukin 6 antagonist | |||
| 0.061 | 0.008 | 0.061 | Liver X receptor beta agonist | |||
| 0.089 | 0.037 | 0.089 | Glutamate decarboxylase inhibitor | |||
| 0.131 | 0.08 | 0.131 | Farnesoid X receptor antagonist | |||
| 0.138 | 0.088 | 0.138 | Phospholipase A2 inhibitor | |||
| 0.167 | 0.117 | 0.167 | Histone acetyltransferase inhibitor | |||
| 0.087 | 0.038 | 0.093 | HIV-1 reverse transcriptase inhibitor | 0.093 0.034 CID_154700092 | CID_154700092 | |
| 0.077 | 0.027 | 0.077 | TRPA1 antagonist | |||
| 0.081 | 0.033 | 0.081 | Nav1.7 sodium channel blocker | |||
| 0.072 | 0.024 | 0.072 | Calcium channel P-type blocker | |||
| 0.075 | 0.027 | 0.075 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.058 | 0.011 | 0.058 | Nerve growth factor antagonist | |||
| 0.059 | 0.011 | 0.059 | Glutamate (mGluR group II) antagonist | |||
| 0.068 | 0.021 | 0.068 | Phosphorylase inhibitor | 0.044 0.034 CID_154700092 | ||
| 0.064 | 0.017 | 0.064 | Dopamine D5 antagonist | |||
| 0.064 | 0.018 | 0.064 | 5 Hydroxytryptamine 2C agonist | |||
| 0.081 | 0.035 | 0.081 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.052 | 0.006 | 0.052 | Ceramide glucosyltransferase inhibitor | 0.051 0.006 CID_154700092 | ||
| 0.05 | 0.006 | 0.05 | NMDA receptor glycine site antagonist | |||
| 0.051 | 0.006 | 0.121 | Kynurenine 3 monooxygenase inhibitor | 0.121 0.003 CID_154700092 | CID_154700092 | |
| 0.119 | 0.075 | 0.119 | DNA repair enzyme inhibitor | |||
| 0.06 | 0.017 | 0.06 | Thymidylate synthase inhibitor | |||
| 0.065 | 0.021 | 0.065 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.059 | 0.015 | 0.059 | Purinergic P2X4 antagonist | |||
| 0.054 | 0.011 | 0.054 | 5 Hydroxytryptamine 2B agonist | |||
| 0.187 | 0.144 | 0.187 | DNA synthesis inhibitor | |||
| 0.137 | 0.094 | 0.137 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.065 | 0.023 | 0.065 | Dihydroorotate oxidase inhibitor | |||
| 0.144 | 0.102 | 0.144 | Antipruritic | |||
| 0.048 | 0.007 | 0.048 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.049 | 0.009 | 0.049 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.069 | 0.029 | 0.069 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.064 | 0.024 | 0.064 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.088 | 0.048 | 0.088 | Topoisomerase II alpha inhibitor | |||
| 0.072 | 0.033 | 0.072 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.053 | 0.014 | 0.053 | Alpha 1d adrenoreceptor agonist | |||
| 0.122 | 0.083 | 0.122 | Vanilloid 1 agonist | |||
| 0.048 | 0.01 | 0.048 | Free fatty acid receptor 1 antagonist | |||
| 0.079 | 0.041 | 0.079 | Phosphofructokinase-1 inhibitor | |||
| 0.108 | 0.07 | 0.108 | MAP kinase 13 inhibitor | |||
| 0.067 | 0.029 | 0.067 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.045 | 0.008 | 0.045 | Estrogen-related receptor beta antagonist | |||
| 0.055 | 0.019 | 0.055 | Benzodiazepine antagonist | |||
| 0.061 | 0.025 | 0.061 | Aconitate hydratase inhibitor | |||
| 0.05 | 0.014 | 0.056 | Phosphoglycerate kinase inhibitor | 0.056 0.012 CID_154700092 | CID_154700092 | |
| 0.098 | 0.062 | 0.098 | Xanthine oxidase inhibitor | |||
| 0.051 | 0.015 | 0.051 | Kainate receptor 2 antagonist | |||
| 0.05 | 0.014 | 0.06 | Farnesoid X receptor agonist | 0.06 0.01 CID_154700092 | CID_154700092 | |
| 0.058 | 0.022 | 0.058 | Potassium channel (Inward rectifier) activator | |||
| 0.066 | 0.031 | 0.066 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.088 | 0.053 | 0.088 | Myeloperoxidase inhibitor | |||
| 0.052 | 0.017 | 0.052 | GABA B receptor antagonist | |||
| 0.056 | 0.022 | 0.056 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.087 | 0.052 | 0.087 | I kappa B kinase inhibitor | |||
| 0.069 | 0.035 | 0.069 | Adrenaline uptake inhibitor | |||
| 0.041 | 0.008 | 0.041 | CXC chemokine 2 receptor antagonist | |||
| 0.048 | 0.015 | 0.048 | p53 inhibitor | |||
| 0.059 | 0.025 | 0.094 | Heparanase inhibitor | 0.094 0.004 CID_154700092 | CID_154700092 | |
| 0.055 | 0.022 | 0.055 | Potassium channel (ATP-sensitive) activator | |||
| 0.046 | 0.013 | 0.046 | Vanilloid 3 antagonist | |||
| 0.043 | 0.01 | 0.043 | Glutamate (mGluR2) antagonist | |||
| 0.075 | 0.042 | 0.075 | Cyclin B3 inhibitor | |||
| 0.054 | 0.022 | 0.054 | Sphingosine 1-phosphate receptor agonist | |||
| 0.143 | 0.111 | 0.143 | DNA methyltransferase I inhibitor | |||
| 0.054 | 0.022 | 0.054 | CC chemokine 4 receptor antagonist | |||
| 0.084 | 0.053 | 0.084 | CC chemokine 5 receptor agonist | |||
| 0.04 | 0.009 | 0.04 | Liver X receptor alpha antagonist | |||
| 0.047 | 0.017 | 0.047 | Heme oxygenase inhibitor | |||
| 0.045 | 0.016 | 0.045 | Glutamate (mGluR3) antagonist | |||
| 0.106 | 0.077 | 0.106 | Photosensitizer | |||
| 0.034 | 0.004 | 0.034 | Nicotinic acid receptor 1 antagonist | |||
| 0.062 | 0.032 | 0.062 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.093 | 0.063 | 0.093 | Prolactin inhibitor | |||
| 0.034 | 0.005 | 0.034 | Alpha 2a adrenoreceptor agonist | |||
| 0.035 | 0.006 | 0.035 | Hedgehog signaling activator | |||
| 0.05 | 0.021 | 0.05 | Kainate receptor antagonist | |||
| 0.045 | 0.017 | 0.045 | Nicotinic acid receptor agonist | |||
| 0.113 | 0.085 | 0.113 | Cathepsin H inhibitor | |||
| 0.084 | 0.056 | 0.084 | Glutathione S-transferase inhibitor | |||
| 0.088 | 0.06 | 0.088 | Bromodomain-containing protein 2 inhibitor | |||
| 0.078 | 0.051 | 0.078 | MAP kinase kinase 7 inhibitor | |||
| 0.075 | 0.048 | 0.075 | Nav1.8 sodium channel blocker | |||
| 0.201 | 0.175 | 0.201 | Vasodilator, peripheral | |||
| 0.043 | 0.018 | 0.043 | Retinoid X alpha receptor agonist | |||
| 0.034 | 0.009 | 0.034 | Sodium/glucose cotransporter inhibitor | |||
| 0.042 | 0.016 | 0.042 | Sirtuin 2 inhibitor | |||
| 0.039 | 0.014 | 0.039 | Liver X receptor antagonist | |||
| 0.054 | 0.029 | 0.054 | Dopamine transporter inhibitor | |||
| 0.03 | 0.004 | 0.03 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.039 | 0.014 | 0.039 | Protein kinase (CK2) beta inhibitor | |||
| 0.047 | 0.022 | 0.047 | Alpha 1L adrenoreceptor agonist | |||
| 0.201 | 0.176 | 0.357 | Antithrombotic | 0.357 0.062 CID_154700092 | CID_154700092 | |
| 0.042 | 0.018 | 0.042 | Integrin alpha2 antagonist | |||
| 0.065 | 0.04 | 0.065 | Transcription factor RelA inhibitor | |||
| 0.082 | 0.058 | 0.082 | T cell inhibitor | |||
| 0.047 | 0.023 | 0.047 | CDK5/p25 inhibitor | |||
| 0.09 | 0.066 | 0.09 | MAO B inhibitor | |||
| 0.044 | 0.021 | 0.044 | Progesterone antagonist | |||
| 0.07 | 0.047 | 0.07 | I kappa B kinase 1 inhibitor | |||
| 0.039 | 0.016 | 0.039 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.057 | 0.034 | 0.057 | GABA receptor antagonist | 0.053 0.04 CID_154700092 | ||
| 0.032 | 0.009 | 0.032 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.029 0.012 CID_154700092 | ||
| 0.042 | 0.019 | 0.042 | Glutamate (mGluR8) agonist | |||
| 0.108 | 0.086 | 0.108 | MAP kinase 12 inhibitor | |||
| 0.078 | 0.055 | 0.078 | Glutamate receptor agonist | |||
| 0.061 | 0.038 | 0.061 | Bcl-xL inhibitor | |||
| 0.045 | 0.023 | 0.045 | Thymidine kinase inhibitor | 0.041 0.028 CID_154700092 | ||
| 0.032 | 0.011 | 0.032 | Integrin alpha2beta1 antagonist | |||
| 0.086 | 0.065 | 0.086 | Potassium channel activator | |||
| 0.041 | 0.019 | 0.041 | Integrin alpha1beta1 antagonist | |||
| 0.06 | 0.039 | 0.06 | EphB4 antagonist | |||
| 0.055 | 0.035 | 0.055 | GABA A receptor antagonist | |||
| 0.033 | 0.012 | 0.033 | Purinergic P2Y15 antagonist | |||
| 0.045 | 0.025 | 0.045 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.064 | 0.044 | 0.064 | Beta 3 adrenoreceptor antagonist | |||
| 0.056 | 0.036 | 0.098 | Adenine nucleotide translocase inhibitor | 0.098 0.005 CID_154700092 | CID_154700092 | |
| 0.075 | 0.054 | 0.229 | Carbonic anhydrase XIII inhibitor | 0.229 0.01 CID_154700092 | CID_154700092 | |
| 0.062 | 0.042 | 0.062 | Beta 2 adrenoreceptor agonist | |||
| 0.056 | 0.036 | 0.056 | Immunoglobulin Fc receptor antagonist | |||
| 0.042 | 0.023 | 0.042 | AMPA 4 receptor antagonist | |||
| 0.024 | 0.005 | 0.024 | Somatostatin 2 agonist | |||
| 0.06 | 0.041 | 0.06 | Androgen agonist | 0.055 0.049 CID_154700092 | ||
| 0.066 | 0.047 | 0.066 | Bcl2 antagonist | |||
| 0.038 | 0.02 | 0.038 | RNA-directed RNA polymerase inhibitor | |||
| 0.043 | 0.024 | 0.043 | Kainate receptor agonist | |||
| 0.03 | 0.012 | 0.036 | Thyroid hormone agonist | 0.036 0.008 CID_154700092 | CID_154700092 | |
| 0.124 | 0.106 | 0.39 | Hemostatic | 0.39 0.008 CID_154700092 | CID_154700092 | |
| 0.085 | 0.068 | 0.085 | ATPase (Vacuolar H+) inhibitor | |||
| 0.25 | 0.233 | 0.25 | MAP kinase 1 inhibitor | |||
| 0.046 | 0.029 | 0.046 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.047 | 0.031 | 0.047 | Carbonic anhydrase VII inhibitor | |||
| 0.05 | 0.034 | 0.05 | Squalene epoxidase inhibitor | |||
| 0.241 | 0.224 | 0.241 | Apoptosis agonist | |||
| 0.095 | 0.079 | 0.095 | Alpha 2b adrenoreceptor antagonist | |||
| 0.06 | 0.045 | 0.06 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.022 | 0.008 | 0.022 | G-protein-coupled receptor 120 agonist | |||
| 0.056 | 0.041 | 0.056 | Xanthine dehydrogenase inhibitor | |||
| 0.154 | 0.14 | 0.154 | Free radical scavenger | |||
| 0.025 | 0.011 | 0.025 | Isoleucine-tRNA ligase inhibitor | |||
| 0.054 | 0.041 | 0.114 | Carbonic anhydrase VB inhibitor | 0.114 0.013 CID_154700092 | CID_154700092 | |
| 0.102 | 0.089 | 0.102 | MAO inhibitor | |||
| 0.037 | 0.024 | 0.037 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.028 | 0.015 | 0.028 | Thymidine phosphorylase inhibitor | |||
| 0.057 | 0.044 | 0.057 | Raf kinase C inhibitor | |||
| 0.069 | 0.057 | 0.069 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.068 | 0.056 | 0.068 | Aminopeptidase I inhibitor | |||
| 0.026 | 0.015 | 0.026 | Complement factor 1s inhibitor | |||
| 0.055 | 0.044 | 0.055 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.066 | 0.055 | 0.066 | Amidase inhibitor | |||
| 0.064 | 0.054 | 0.064 | Glutamate (mGluR7) antagonist | |||
| 0.019 | 0.008 | 0.019 | CC chemokine 9 receptor antagonist | |||
| 0.049 | 0.039 | 0.049 | CXC chemokine 1 receptor antagonist | |||
| 0.085 | 0.076 | 0.085 | 5-Lipoxygenase inhibitor | |||
| 0.033 | 0.023 | 0.033 | Catechol O-methyltransferase inhibitor | |||
| 0.049 | 0.04 | 0.067 | Aldose reductase inhibitor | 0.067 0.029 CID_154700092 | CID_154700092 | |
| 0.054 | 0.046 | 0.054 | Leukotriene C antagonist | |||
| 0.065 | 0.057 | 0.065 | Protein kinase C beta inhibitor | |||
| 0.1 | 0.092 | 0.1 | Microtubule formation inhibitor | |||
| 0.04 | 0.033 | 0.04 | Cathepsin F inhibitor | |||
| 0.018 | 0.012 | 0.018 | Complement factor D inhibitor | |||
| 0.011 | 0.005 | 0.011 | Progesterone receptor A antagonist | |||
| 0.03 | 0.024 | 0.03 | HCV NS5B polymerase inhibitor | |||
| 0.032 | 0.027 | 0.032 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.035 | 0.03 | 0.035 | TRPM8 blocker | |||
| 0.014 | 0.008 | 0.014 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.041 | 0.036 | 0.049 | Dihydrofolate reductase inhibitor | 0.049 0.02 CID_154700092 | CID_154700092 | |
| 0.016 | 0.011 | 0.016 | Thyroid hormone alpha agonist | |||
| 0.058 | 0.053 | 0.058 | 5 Hydroxytryptamine 3 agonist | |||
| 0.04 | 0.035 | 0.04 | Liver X receptor agonist | |||
| 0.066 | 0.062 | 0.066 | Alpha 2a adrenoreceptor antagonist | |||
| 0.055 | 0.05 | 0.067 | Sphingosine kinase inhibitor | 0.067 0.028 CID_154700092 | CID_154700092 | |
| 0.031 | 0.027 | 0.031 | Fumarate hydratase inhibitor | |||
| 0.051 | 0.047 | 0.051 | Thromboxane synthase inhibitor | |||
| 0.181 | 0.177 | 0.181 | Gastrin inhibitor | |||
| 0.053 | 0.049 | 0.053 | Biliverdin reductase inhibitor | |||
| 0.051 | 0.047 | 0.051 | DNA helicase inhibitor | |||
| 0.064 | 0.061 | 0.064 | Secretase beta inhibitor | |||
| 0.036 | 0.033 | 0.036 | GABA uptake inhibitor | |||
| 0.027 | 0.024 | 0.027 | Estrogen-related receptor gamma antagonist | |||
| 0.015 | 0.012 | 0.015 | Thromboxane A2 agonist | |||
| 0.012 | 0.009 | 0.012 | Egl nine homolog 3 inhibitor | |||
| 0.069 | 0.067 | 0.069 | Potassium channel (Tandem pore domain) blocker | |||
| 0.028 | 0.026 | 0.028 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.066 | 0.064 | 0.081 | Na+ K+ transporting ATPase inhibitor | 0.081 0.049 CID_154700092 | CID_154700092 | |
| 0.024 | 0.023 | 0.024 | Complement factor 1r inhibitor | |||
| 0.111 | 0.109 | 0.111 | Activin receptor-like kinase 2 inhibitor | |||
| 0.066 | 0.065 | 0.215 | CDC25A inhibitor | 0.215 0.005 CID_154700092 | CID_154700092 | |
| 0.058 | 0.057 | 0.206 | Carbonic anhydrase V inhibitor | 0.206 0.006 CID_154700092 | CID_154700092 | |
| 0.019 | 0.018 | 0.019 | Imidazoline I1 receptor antagonist | |||
| 0.118 | 0.117 | 0.118 | Sigma receptor agonist | |||
| 0.097 | 0.096 | 0.097 | Caspase 3 inhibitor | |||
| 0.03 | 0.029 | 0.03 | Glutamate (mGluR3) agonist | |||
| 0.007 | 0.006 | 0.007 | DNA topoisomerase III inhibitor | |||
| 0.037 | 0.036 | 0.037 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.014 | 0.013 | 0.014 | Thyroid hormone alpha antagonist | |||
| 0.152 | 0.153 | 0.191 | Immunostimulant | 0.191 0.126 CID_154700092 | CID_154700092 | |
| 0.037 | 0.039 | 0.046 | Guanylate cyclase inhibitor | 0.046 0.025 CID_154700092 | CID_154700092 | |
| 0.017 | 0.025 | 0.052 | Glutamate (mGluR1a) agonist | 0.052 0.005 CID_154700092 | CID_154700092 | |
| 0.013 | 0.022 | 0.034 | Sodium/hydrogen exchanger inhibitor | 0.034 0.005 CID_154700092 | CID_154700092 | |
| 0.021 | 0.031 | 0.202 | NMDA 2D receptor antagonist | 0.202 0.003 CID_154700092 | CID_154700092 | |
| 0.056 | 0.067 | 0.141 | Carbonic anhydrase VA inhibitor | 0.141 0.013 CID_154700092 | CID_154700092 | |
| 0.042 | 0.054 | 0.141 | Factor IXa inhibitor | 0.141 0.004 CID_154700092 | CID_154700092 | |
| 0.027 | 0.04 | 0.101 | Factor XI inhibitor | 0.101 0.004 CID_154700092 | CID_154700092 | |
| 0.092 | 0.108 | 0.142 | Acetylcholine release stimulant | 0.142 0.022 CID_154700092 | CID_154700092 | |
| 0.036 | 0.055 | 0.071 | Carbonic anhydrase IX inhibitor | 0.071 0.032 CID_154700092 | CID_154700092 | |
| 0.08 | 0.103 | 0.179 | Protein-tyrosine phosphatase 1B inhibitor | 0.179 0.035 CID_154700092 | CID_154700092 | |
| 0.055 | 0.078 | 0.149 | Cathepsin G inhibitor | 0.149 0.021 CID_154700092 | CID_154700092 | |
| 0.146 | 0.17 | 0.236 | Antioxidant | 0.236 0.091 CID_154700092 | CID_154700092 | |
| 0.012 | 0.038 | 0.077 | Estrone sulfatase inhibitor | 0.077 0.005 CID_154700092 | CID_154700092 | |
| 0.015 | 0.042 | 0.028 | Dopamine D1 agonist | 0.028 0.01 CID_154700092 | CID_154700092 | |
| 0.034 | 0.064 | 0.071 | Carbonic anhydrase II inhibitor | 0.071 0.029 CID_154700092 | CID_154700092 | |
| 0.039 | 0.072 | 0.171 | Carbonic anhydrase inhibitor | 0.171 0.013 CID_154700092 | CID_154700092 | |
| 0.039 | 0.073 | 0.453 | NMDA 2B receptor antagonist | 0.453 0.004 CID_154700092 | CID_154700092 | |
| 0.039 | 0.074 | 0.052 | Alpha-mannosidase inhibitor | 0.052 0.04 CID_154700092 | CID_154700092 | |
| 0.026 | 0.063 | 0.097 | Factor XIa inhibitor | 0.097 0.005 CID_154700092 | CID_154700092 | |
| 0.079 | 0.118 | 0.16 | Nav1.4 sodium channel blocker | 0.16 0.03 CID_154700092 | CID_154700092 | |
| 0.016 | 0.063 | 0.023 | Glutamate (mGluR1) agonist | 0.023 0.02 CID_154700092 | CID_154700092 | |
| 0.024 | 0.085 | 0.085 | Carbonic anhydrase I inhibitor | 0.085 0.023 CID_154700092 | CID_154700092 | |
| 0.02 | 0.082 | 0.058 | Purinergic P2Y2 antagonist | 0.058 0.008 CID_154700092 | CID_154700092 | |
| 0.067 | 0.159 | 0.287 | Multidrug resistance-associated protein 1 inhibitor | 0.287 0.004 CID_154700092 | CID_154700092 | |
| 0.014 | 0.111 | 0.102 | Factor Xa inhibitor | 0.102 0.013 CID_154700092 | CID_154700092 | |
| 0.049 | 0.152 | 0.08 | Inducible nitric-oxide synthase inhibitor | 0.08 0.061 CID_154700092 | CID_154700092 | |
| 0.013 | 0.126 | 0.077 | Dopamine D2 agonist | 0.077 0.015 CID_154700092 | CID_154700092 | |
| 0.017 | 0.152 | 0.077 | Leukocyte elastase inhibitor | 0.077 0.013 CID_154700092 | CID_154700092 | |
| 0.078 | 0.249 | 0.166 | Hepatoprotectant | 0.166 0.093 CID_154700092 | CID_154700092 | |
| 0.007 | 0.243 | 0.041 | 1,3-Beta-glucan synthase inhibitor | 0.041 0.004 CID_154700092 | CID_154700092 | |
| 0.004 | 0.283 | 0.849 | Cholecystokinin A agonist | 0.849 0.001 CID_154700092 | CID_154700092 | |
| 0.034 | 0.32 | 0.095 | Breast cancer-resistant protein inhibitor | 0.095 0.06 CID_154700092 | CID_154700092 | |
| 0.02 | 0.312 | 0.078 | MAP kinase kinase 10 inhibitor | 0.078 0.031 CID_154700092 | CID_154700092 | |
| 0.004 | 0.333 | 0.863 | Cholecystokinin agonist | 0.863 0.001 CID_154700092 | CID_154700092 | |
| 0.126 | 0.465 | 0.603 | Antiinflammatory | 0.603 0.053 CID_154700092 | CID_154700092 | |
| 0.014 | 0.354 | 0.064 | Neuraminidase (influenza) inhibitor | 0.064 0.045 CID_154700092 | CID_154700092 | |
| 0.012 | 0.356 | 0.037 | Toll-Like receptor 4 agonist | 0.037 0.006 CID_154700092 | CID_154700092 | |
| 0.034 | 0.403 | 0.427 | Angiogenesis stimulant | 0.427 0.018 CID_154700092 | CID_154700092 | |
| 0.009 | 0.384 | 0.21 | Selectin antagonist | 0.21 0.01 CID_154700092 | CID_154700092 | |
| 0.024 | 0.49 | 0.557 | Anticoagulant | 0.557 0.007 CID_154700092 | CID_154700092 | |
| 0.003 | 0.517 | 0.556 | Cholecystokinin A antagonist | 0.556 0.003 CID_154700092 | CID_154700092 | |
| 0.018 | 0.544 | 0.143 | Thrombolytic | 0.143 0.088 CID_154700092 | CID_154700092 | |
| 0.004 | 0.548 | 0.46 | Cholecystokinin antagonist | 0.46 0.003 CID_154700092 | CID_154700092 | |
| 0.003 | 0.614 | 0.445 | Cholecystokinin B antagonist | 0.445 0.003 CID_154700092 | CID_154700092 | |
| 0.009 | 0.628 | 0.949 | Cholecystokinin B agonist | 0.949 0.001 CID_154700092 | CID_154700092 | |
| 0.026 | 0.65 | 0.297 | Angiogenesis inhibitor | 0.297 0.094 CID_154700092 | CID_154700092 | |
| 0.009 | 0.633 | 0.094 | Thrombin inhibitor | 0.094 0.029 CID_154700092 | CID_154700092 | |
| 0.005 | 0.722 | 0.092 | Elastase inhibitor | 0.092 0.012 CID_154700092 | CID_154700092 | |
| 0.018 | 0.745 | 0.266 | Platelet adhesion inhibitor | 0.266 0.044 CID_154700092 | CID_154700092 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |